GlassScriptPhysician profile
Thomas J Klein
NPI 1396902813
$4,938.86
in general payments reported to CMS, 2019-2025
23 companies · $303 in 2025
The $303 reported for 2025 was more than what a typical Radiation Oncology provider received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $61.09 · 2020: $193 · 2021: $270 · 2022: $2,088 · 2023: $396 · 2024: $1,628 · 2025: $303.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $867 · Travel and Lodging: $860 · Education: $600.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $867.27 |
| Travel and Lodging | $859.62 |
| Education | $600.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novocure INC. | $2,109.14 | 2021-2024 | Optune |
| Carl Zeiss Meditec USA, INC. | $1,459.62 | 2024 | Intrabeam, Iort |
| Boston Scientific Corporation | $218.15 | 2023-2025 | Spaceoar Vue System - 10ml |
| Astrazeneca Pharmaceuticals LP | $199.88 | 2019-2025 | Tagrisso |
| Genzyme Corporation | $113.79 | 2021 | |
| Advanced Accelerator Applications | $107.49 | 2020 | |
| Merck Sharp & Dohme LLC | $99.13 | 2019-2025 | Keytruda, Lynparza |
| E.R. Squibb & Sons, L.L.C. | $99.02 | 2020-2021 | |
| Myriad Genetic Laboratories, INC. | $91.80 | 2023 | Prolaris |
| Pfizer INC. | $80.54 | 2025 | |
| Novartis Pharmaceuticals Corporation | $56.04 | 2022-2023 | Cosentyx |
| Astellas Pharma US INC | $48.83 | 2025 | Vyloy |
| Tactile Systems Technology INC | $37.69 | 2023-2024 | Flexitouch Plus, Entre Plus |
| Telix Pharmaceuticals | $29.87 | 2024 | Illuccix |
| Napo Pharmaceuticals INC | $29.28 | 2025 | Gelclair Concentrated Oral Gel |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Blue Earth Diagnostics | $25.85 | 2021 | |
| Sumitomo Pharma America, INC. | $24.27 | 2025 | Orgovyx |
| Janssen Biotech, INC. | $23.44 | 2022 | |
| Seagen INC. | $21.95 | 2022 | |
| Lilly USA, LLC | $16.96 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $15.84 | 2020 | |
| Fortovia Therapeutics, INC. | $15.35 | 2019 | |
| Sirtex Medical INC | $14.93 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Klein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.